Report cover image

South & Central America Small Molecule Drug Discovery Market Size and Forecast (2021 - 2031)

Publisher The Insight Partners
Published Jan 14, 2026
SKU # TIP20949678

Description

The South and Central America Small Molecule Drug Discovery Market is projected to grow significantly, reaching approximately US$ 3,101.1 million by 2031, up from US$ 1,689.0 million in 2023, with an estimated compound annual growth rate (CAGR) of 7.9% from 2023 to 2031.

Executive Summary and Market Analysis

The market for small molecule drug discovery in South and Central America is categorized by countries, including Brazil, Argentina, and other regions. The growth in this market is primarily driven by improvements in healthcare infrastructure and increased awareness of ear-related health issues. Brazil is a key player in this market, largely due to the rising prevalence of chronic ear infections and hearing disorders that require tympanostomy procedures. The country's expanding biotechnology and biopharmaceutical sectors are enhancing access to advanced medical devices and innovative treatments. Additionally, ongoing healthcare reforms and government initiatives aimed at improving medical care are further propelling market growth across the region. Argentina and other countries are also seeing a rise in the adoption of tympanostomy products, thanks to better diagnostic capabilities and a stronger focus on ear health for both children and adults. Collectively, these factors are expected to create significant opportunities for the tympanostomy products market in the coming years.

Strategic Insights

Market Segmentation Analysis
  • By Therapeutic Area: The market is divided into several therapeutic areas, including Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and others. Oncology held the largest market share in 2023.
  • By Process or Phase: The market is also segmented by the drug discovery process, including Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development, with Lead Generation and Refinement being the largest segment in 2023.
Market Outlook

In recent years, the pharmaceutical industry has seen a surge in outsourcing services, driven by factors such as the increasing use of small molecules, the complexity of active pharmaceutical ingredients (APIs), and the need to lower development costs. Major pharmaceutical companies are outsourcing research and development (R&D) activities to accelerate drug development and reduce expenses. This trend is particularly evident as companies seek to manage the complexities associated with new molecular entities (NMEs) and prefer to outsource to contract research organizations (CROs) for their specialized capabilities. The rise in new drug approvals and a robust clinical development pipeline are further fueling the demand for outsourcing. Many biotechnology firms are leveraging CROs to enhance their small molecule pipelines, and this trend is expected to continue as companies aim to streamline their operations. CROs offer a range of services, including product development, clinical trial support, manufacturing, and commercialization, allowing small molecule drug companies to scale efficiently and access technical expertise without incurring high overhead costs.

Country Insights

The South and Central America Small Molecule Drug Discovery Market is segmented by country, with Brazil holding the largest market share in 2023. Brazil is recognized as an emerging pharmaceutical market, facing a growing prevalence of chronic diseases such as cancer and diabetes. The International Diabetes Federation (IDF) estimates that the number of people with diabetes in Brazil will rise from 15.7 million in 2021 to 23.2 million by 2045, driving demand for small molecule drugs. Brazil's rich pool of intellectual resources engaged in R&D for new therapeutic solutions positions it well for growth in the small molecule drug discovery market.

Company Profiles

Key players in the South and Central America Small Molecule Drug Discovery Market include GSK Plc, Charles River Laboratories International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Merck KGaA, ICON Plc, Revvity Inc., Danaher Corp, Thermo Fisher Scientific Inc., and Oncodesign Services. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. South & Central America Small Molecule Drug Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Small Molecule Drug Discovery Market - South & Central America Market Analysis
5.1 South & Central America Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
5.2 South & Central America Small Molecule Drug Discovery Market Forecast and Analysis
6. South & Central America Small Molecule Drug Discovery Market Revenue Analysis - by Therapeutic Area
6.1 Oncology
6.1.1 Overview
6.1.2 Oncology: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Central Nervous System
6.2.1 Overview
6.2.2 Central Nervous System: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Cardiovascular
6.3.1 Overview
6.3.2 Cardiovascular: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.4 Respiratory
6.4.1 Overview
6.4.2 Respiratory: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.5 Orthopedics
6.5.1 Overview
6.5.2 Orthopedics: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.6 Immunology
6.6.1 Overview
6.6.2 Immunology: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.7 Rare Diseases
6.6.1 Overview
6.6.2 Rare Diseases: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.8 Other Therapeutic Areas
6.8.1 Overview
6.8.2 Other Therapeutic Areas: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. South & Central America Small Molecule Drug Discovery Market Revenue Analysis - by Process Or Phase
7.1 Target Discovery
7.1.1 Overview
7.1.2 Target Discovery: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Target Validation
7.2.1 Overview
7.2.2 Target Validation: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Lead Generation and Refinement
7.3.1 Overview
7.3.2 Lead Generation and Refinement: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Preclinical Development
7.4.1 Overview
7.4.2 Preclinical Development: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. South & Central America Small Molecule Drug Discovery Market - Country Analysis
8.1 South & Central America
8.1.1 South & Central America Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.1.1 South & Central America Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.2.2 Brazil: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2.2.1 Brazil: South & Central America Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.1.2.2.2 Brazil: South & Central America Small Molecule Drug Discovery Market Share - by Process Or Phase
8.2.3.3 Argentina: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2.3.3.1 Argentina: South & Central America Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.2.3.3.2 Argentina: South & Central America Small Molecule Drug Discovery Market Share - by Process Or Phase
8.3.4.4 Rest of South & Central America: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3.4.4.1 Rest of South & Central America: South & Central America Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.3.4.4.2 Rest of South & Central America: South & Central America Small Molecule Drug Discovery Market Share - by Process Or Phase
9 Industry Landscape
9.1 Overview
12 COMPANY PROFILES
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Charles River Laboratories International Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Bristol-Myers Squibb Co
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Merck KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 ICON Plc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Revvity Inc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Danaher Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Oncodesign Services
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
LIST OF TABLES
Table 1. South & Central America Small Molecule Drug Discovery Market Segmentation
Table 3. South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 5. South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 6. South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 7. Brazil: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 8. Brazil: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 9. Argentina: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 10. Argentina: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 11. Rest of South & Central America: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 12. Rest of South & Central America: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 13. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. South & Central America Small Molecule Drug Discovery Market Segmentation - Country
Figure 4. South & Central America Small Molecule Drug Discovery Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
Figure 7. South & Central America Small Molecule Drug Discovery Market Share (%) - by Therapeutic Area, 2023 and 2031
Figure 8. Oncology: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Central Nervous System: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardiovascular: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Respiratory: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Orthopedics: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Immunology: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Rare Diseases: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Other Therapeutic Areas: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. South & Central America Small Molecule Drug Discovery Market Share (%) - by Process Or Phase, 2023 and 2031
Figure 17. Target Discovery: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Target Validation: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Lead Generation and Refinement: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Preclinical Development: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South & Central America Small Molecule Drug Discovery Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 22. Brazil: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Argentina: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of South & Central America: South & Central America Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us